- Home
- WST vs GFS Comparison
WST vs GFS Comparison
Compare WST & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- GFS
- Stock Information
- Founded
- WST 1923
- GFS 2009
- Country
- WST United States
- GFS United States
- Employees
- WST N/A
- GFS N/A
- Industry
- WST Medical/Dental Instruments
- GFS Semiconductors
- Sector
- WST Health Care
- GFS Technology
- Exchange
- WST Nasdaq
- GFS Nasdaq
- Market Cap
- WST 23.2B
- GFS 24.2B
- IPO Year
- WST N/A
- GFS 2021
- Fundamental
- Price
- WST $331.61
- GFS $43.98
- Analyst Decision
- WST Strong Buy
- GFS Buy
- Analyst Count
- WST 3
- GFS 15
- Target Price
- WST $465.33
- GFS $51.07
- AVG Volume (30 Days)
- WST 449.7K
- GFS 1.5M
- Earning Date
- WST 10-24-2024
- GFS 02-11-2025
- Dividend Yield
- WST 0.25%
- GFS N/A
- EPS Growth
- WST N/A
- GFS N/A
- EPS
- WST 6.74
- GFS 1.32
- Revenue
- WST $2,876,400,000.00
- GFS $6,774,000,000.00
- Revenue This Year
- WST N/A
- GFS N/A
- Revenue Next Year
- WST $6.22
- GFS $9.81
- P/E Ratio
- WST $48.92
- GFS $33.48
- Revenue Growth
- WST N/A
- GFS N/A
- 52 Week Low
- WST $265.00
- GFS $35.85
- 52 Week High
- WST $413.70
- GFS $62.61
- Technical
- Relative Strength Index (RSI)
- WST 59.78
- GFS 53.77
- Support Level
- WST $313.92
- GFS $44.00
- Resistance Level
- WST $327.47
- GFS $46.65
- Average True Range (ATR)
- WST 6.66
- GFS 1.40
- MACD
- WST -0.04
- GFS -0.08
- Stochastic Oscillator
- WST 91.37
- GFS 44.37
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About GFS GlobalFoundries Inc.
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 12,000 people.